PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1115 (106th)

Immunosuppresive Drug Coverage Extension Act of 1999

referredUnited States· United States Congress· EN

Introduced

16 March 1999

Last action

7 April 1999 · Referred

Status

Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.

Sponsors

Rep. Canady, Charles T. [R-FL-12], Rep. Thurman, Karen L. [D-FL-5], Rep. Abercrombie, Neil [D-HI-1], Rep. Ackerman, Gary L. [D-NY-7], Rep. Allen, Thomas H. [D-ME-1], Rep. Baldacci, John Elias [D-ME-2], Rep. Barrett, Bill [R-NE-3], Rep. Bentsen, Ken [D-TX-25], Rep. Boehlert, Sherwood [R-NY-25], Rep. Borski, Robert A. [D-PA-3], Rep. Boucher, Rick [D-VA-9], Sen. Coburn, Tom [R-OK], Rep. Cooksey, John [R-LA-5], Rep. Coyne, William J. [D-PA-14], Rep. Deal, Nathan [R-GA-9], PETER DEFAZIO, ELIOT ENGEL, Rep. English, Phil [R-PA-3], Rep. Filner, Bob [D-CA-51], Rep. Foley, Mark [R-FL-16], Rep. Frank, Barney [D-MA-4], Rep. Franks, Bob [R-NJ-7], Rep. Frost, Martin [D-TX-24], Rep. Gallegly, Elton [R-CA-21], Rep. Gilchrest, Wayne T. [R-MD-1], Rep. Goss, Porter J. [R-FL-13], Sen. Graham, Lindsey [R-SC], GENE GREEN, LUIS GUTIERREZ, Rep. Hall, Tony P. [D-OH-3], Rep. Hayworth, J. D. [R-AZ-5], Rep. Inslee, Jay [D-WA-1], Rep. Jenkins, William L. [R-TN-1], Rep. Johnson, Nancy L. [R-CT-6], Rep. Kilpatrick, Carolyn C. [D-MI-13], Rep. Kleczka, Gerald D. [D-WI-4], Rep. Kolbe, Jim [R-AZ-5], Rep. LaFalce, John J. [D-NY-36], Rep. Matsui, Robert T. [D-CA-3], Rep. Mascara, Frank [D-PA-20], Rep. McCollum, Bill [R-FL-5], James McGovern, Rep. McHugh, John M. [R-NY-23], Rep. Mink, Patsy T. [D-HI-2], Rep. Moakley, John Joseph [D-MA-9], Rep. Morella, Constance A. [R-MD-8], Rep. Nethercutt, George R., Jr. [R-WA-5], Rep. Olver, John W. [D-MA-1]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Summary

Immunosuppressive Drug Coverage Extension Act of 1999 - Amends title XVIII (Medicare) of the Social Security Act to eliminate the time limitation on Medicare benefits for immunosuppressive drugs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 16 March 1999

    Introduced

    Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 16 March 1999

    Introduced

    Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 16 March 1999

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 16 March 1999

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 23 March 1999

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  6. 7 April 1999

    Referred

    Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Showing 48 of 277 sponsors and actors.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.